Barclays Lowers RadNet Price Target Amid Continued Outperformance of Imaging Business
On May 20, Barclays analyst Andrew Mok reduced the price target for RadNet (NASDAQ:RDNT) to $65 from $70 while maintaining an Overweight rating. The firm noted that RadNet's imaging business continues to outperform Lumexa in terms of volume growth and pricing.
Tickers: $RDNT
Topics: imaging business performance joint venture stock analysis